Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Journal of Cellular and Molecular Medicine|March 11, 2015
Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6Jingmin Zhou, Kun Jiang, Xuefeng Ding, et al.
In Vitro Cellular & Developmental Biology. Animal|September 11, 2019
Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathwayYanyan Wang, Yuyuan Fan, Yu Song, et al.
International Journal of Cardiology|February 6, 2020
Prognostic value of sST2 in patients with heart failure with reduced, mid-range and preserved ejection fractionYu Song, Fuhai Li, Yamei Xu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 8, 2026
Shexiang Baoxin pill in patients with stable coronary artery disease and reduced eGFR: Subgroup analysis of phase IV randomized trialJingmin Zhou, Yanqiu Chen, Haiming Shi, et al.
Journal of Cardiovascular Translational Research|October 18, 2019
Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta ConstrictionXueting Han, Yanyan Wang, Mingqiang Fu, et al.
European Journal of Heart Failure|September 22, 2025
Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF-CAP) in ChinaJingmin Zhou, Xuejuan Jin, Yamei Xu, et al.
Journal of Cardiovascular Pharmacology|November 15, 2011
Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in miceYunzeng Zou, Li Lin, Yong Ye, et al.
Journal of the American Heart Association|March 17, 2021
Association of Small Intestinal Bacterial Overgrowth With Heart Failure and Its Prediction for Short-Term OutcomesYu Song, Yuan Liu, Baozhen Qi, et al.
Pageof 11